All but two of the 33 sector sub-indexes on the Tokyo exchange traded lower, with real estate, pharmaceuticals and land transport leading t...

As US regulators tighten the scrutiny around approvals, companies have announced their intention to put their trial data in public domain f...

Indian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, current...

The Nikkei ended 0.17% higher at 23,289.36, briefly hitting a six-month high for two straight sessions, but did not rise enough to close a ...

Favipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...

A total of 9,119 shares changed hands on the counter till 11:07AM (IST).

The agreement provides for Fujifilm Toyama Chemical, a unit of the Japanese company to grant Dr. Reddy's and Dubai-based Global Response Ai...

This follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...

Favipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...

The study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...

The Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country...

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...

The drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...

The benchmark Nikkei average gained 4.2 per cent to 18,576.30, its highest close in nearly a week, tracking sharp gains in US stock futures.

Nikkei index ended up 0.01 per cent at 17,820.19 in a subdued session that saw shares bounce between gains and losses.

The update on the trials’ progress came a day after the World Health Organization said that remdesivir may be the only effective treatment ...